期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | FOLIA NEUROPATHOLOGICA LetPub Score 4.8
50 ratings
Rate
Reputation 5.7 Influence 3.6 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | FOLIA NEUROPATHOL | ||||||||||||||||||||
ISSN | 1641-4640 | ||||||||||||||||||||
E-ISSN | 1509-572X | ||||||||||||||||||||
h-index | 31 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.termedia.pl/Journal/-20 | ||||||||||||||||||||
在線稿件提交 | http://www.editorialsystem.com/fn | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Termedia Publishing House Ltd. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | POLAND | ||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||
創刊年 | 1994 | ||||||||||||||||||||
每年文章數 | 49每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 98.57% | ||||||||||||||||||||
OA Related Info | APC: Yes( EUR250; ) APC waiver:No Other charges: Check Notes Keywords: clinical and experimental neuropathology、neuroscience research Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1641-4640%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[FOLIA NEUROPATHOLOGICA] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:44:10 評論於 Post hoc comparison refers to setting additional groups based on the characteristics of the data after data collection is completed, proposing research hypotheses, and conducting statistical analysis; it is to test non-research hypotheses and further exploratory analysis of the results(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:18:11 評論於 Comparing afterwards is testing non-research hypotheses. This is very common in actual research: I have completed the experiment, confirmed the hypothesis, but still need to extend the research, so I need to continue exploring the data to see which direction will lead to valuable conclusions. At this point, it is equivalent to testing all possible comparisons (although I cannot actually exhaust all comparisons, all comparisons are potential possibilities due to no specific purpose). Because comparison does not just refer to the difference in means of two treatments, linear combinations of multiple treatments are also comparisons(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 15:19:59 評論於 Why conduct post-inspection?(0) 讚! | Oswald Edie |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 22:05:40 評論於 What is post-hoc testing?(0) 讚! | 龙鳞孝礼 |
作者: 降龙霞影 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-03-28 19:21:41 評論於 How to recommend reviewers span class "quote" mlainian 20140807 publication br Research direction: neuropathological diagnosis Acceptance rate: about 50% Review time: about 2 months The journal is very friendly. I have published a paper in 2014 and felt that it is relatively friendly to Chinese people, but the publication process is too slow. It generally takes a year and a half from submission to publication(0) 讚! | 降龙霞影 |
作者: 邻家运馨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-11-29 19:13:27 評論於 How long does it take to be accepted for submission? Accepted online?(0) 讚! | 邻家运馨 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 20:02:53 評論於 So-so, as long as I can graduate, it's all good. My senior brother published a paper last year, which also counts as a successful graduation. Everything will be fine(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 18:12:42 評論於 So-so, as long as you can graduate, everything will be fine. My senior brother published a paper last year, which can be considered as a successful graduation, so everything will be all right(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-08-07 18:12:11 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: The journal is very friendly. I had an article published there in 2014 and felt that they were quite friendly towards Chinese authors. However, the publishing process is very slow, taking about a year and a half from submission to publication(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us